wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q39115623-4950A308-FA27-4752-BBD1-E9D9F5623B5A
Q39115623-4950A308-FA27-4752-BBD1-E9D9F5623B5A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39115623-4950A308-FA27-4752-BBD1-E9D9F5623B5A
Dose selection for the investigational anticancer agent alisertib (MLN8237): Pharmacokinetics, pharmacodynamics, and exposure-safety relationships.
P2860
Q39115623-4950A308-FA27-4752-BBD1-E9D9F5623B5A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39115623-4950A308-FA27-4752-BBD1-E9D9F5623B5A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
695eb4c1c4c41d688a51ef7307edb0260b893e0e
P2860
Fixed-dose capecitabine is feasible: results from a pharmacokinetic and pharmacogenetic study in metastatic breast cancer.